Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents.

Seher SenerOzge BasaranUmmusen Kaya AkcaErdal AtalayMuserref Kasap CuceogluZeynep BalikEmil AliyevYagmur BayindirEzgi Deniz BatuTuncay HazirolanYelda BilginerSeza Ozen

Published in: Rheumatology (Oxford, England) (2022)

In conclusion, both TNF-α and IL-6 inhibitors are effective alternatives in treating patients with childhood-onset TA. However, prospective randomized controlled trials are needed for the comparison of their effectiveness.

Keyphrases

randomized controlled trial
rheumatoid arthritis
early life
systematic review
childhood cancer
study protocol
combination therapy
young adults
meta analyses